The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome

Molecular Nutrition and Food Research

Volumn 56, Issue 8, 2012, Pages 1234-1246

  Wang, Ye ^a   Jacome Sosa, Maria M ^a   Ruth, Megan R ^a   Lu, Yan ^e   Shen, Jianheng ^b   Reaney, Martin J ^b   Scott, Shannon L ^c   Dugan, Michael E R ^d   Anderson, Hope D ^e   Field, Catherine J ^a   Proctor, Spencer D ^a   Vine, Donna F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c BRANDON RESEARCH CENTRE   (Canada)

^d LACOMBE RESEARCH CENTRE   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Conjugated linoleic acid; Dyslipidemia; Metabolic syndrome; Peroxisome proliferator activated receptor; Vaccenic acid

Indexed keywords

11-OCTADECENOIC ACID; FATTY ACID; OLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VACCENIC ACID;

ANIMAL; ARTICLE; BINDING COMPETITION; BINDING SITE; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; DYSLIPIDEMIA; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; INTESTINE ABSORPTION; INTESTINE MUCOSA; LIPID METABOLISM; LIVER; MALE; MESENTERY; METABOLIC SYNDROME X; METABOLISM; PATHOLOGY; RAT; RAT STRAIN;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FATTY ACIDS; GENE EXPRESSION REGULATION; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LIPID METABOLISM; LIVER; MALE; MESENTERY; METABOLIC SYNDROME X; MYOCYTES, CARDIAC; OLEIC ACIDS; PPAR ALPHA; PPAR GAMMA; RATS; RATS, INBRED STRAINS;

EID: 84865131463     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100517     Document Type: Article

References (42)

1. Lloyd-Jones, D. M., Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010, 121, 1768-1777.
2. Micha, R., Mozaffarian, D., Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat. Rev. Endocrinol. 2009, 5, 335-344.
3. Field, C. J., Blewett, H. H., Proctor, S., Vine, D., Human health benefits of vaccenic acid. Appl. Physiol. Nutrition Metab. 2009, 34, 979-991.
4. Aro, A., Complexity of issue of dietary trans fatty acids. Lancet 2001, 357, 732-733.
5. Bhattacharya, A., Banu, J., Rahman, M., Causey, J. et al., Biological effects of conjugated linoleic acids in health and disease. J. Nutr. Biochem. 2006, 17, 789-810.
6. Wang, Y., Lu, J., Ruth, M. R., Goruk, S. D. et al., Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. J. Nutr. 2008, 138, 2117-2122.
7. Wang, Y., Jacome-Sosa, M. M., Ruth, M. R., Goruk, S. D. et al., Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J. Nutr. 2009, 139, 2049-2054.
8. Blewett, H. J., Gerdung, C. A., Ruth, M. R., Proctor, S. D. et al., Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br. J. Nutr. 2009, 102, 526-536.
9. Ruth, M. R., Wang, Y., Yu, H. M., Goruk, S. D. et al., Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR:LA-cp rats. Nutrients 2010, 2, 17.
10. Tyburczy, C., Major, C., Lock, A. L., Destaillats, F. et al., Individual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters. J. Nutr. 2009, 139, 257-263.
11. Brown, J. D., Plutzky, J., Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 2007, 115, 518-533.
12. Harris, W. S., Miller, M., Tighe, A. P., Davidson, M. H. et al., Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197, 12-24.
13. Gani, O. A., Sylte, I., Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha. J. Mol. Graph Model 2008, 27, 217-224.
14. Taylor, C. G., Zahradka, P., Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am. J. Clin. Nutr. 2004, 79, 1164S-1168S.
15. Alibin, C. P., Kopilas, M. A., Anderson, H. D., Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma. J. Biol. Chem. 2008, 283, 10707-10715.
16. Motard-Belanger, A., Charest, A., Grenier, G., Paquin, P. et al., Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am. J. Clin. Nutr. 2008, 87, 593-599.
17. Chardigny, J. M., Masson, E., Sergiel, J. P., Darbois, M. et al., The position of rumenic acid on triacylglycerols alters its bioavailability in rats. J.Nutr. 2003, 133, 4212-4214.
18. Tricon, S., Burdge, G. C., Jones, E. L., Russell, J. J. et al., Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am. J. Clin. Nutr. 2006, 83, 744-753.
19. Russell, J. C., Proctor, S. D., Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc. Pathol. 2006, 15, 318-330.
20. Mouloungui, Z., Candy, L., in: Destaillats, F. (Ed.), Trans Fatty Acids in Human Nutrition, The Oily Press, High Wycombe, UK, 2009, p. 77.
21. Russell, J. C., Amy, R. M., Graham, S. E., Dolphin, P. J. et al., Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta'-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler. Thromb. Vasc. Biol. 1995, 15, 918-923.
22. Weiser, M. M., Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J. Biol. Chem. 1973, 248, 2536-2541.
23. Suzuki, T., Hoshi, H., Mitsui, Y., Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. FEBS Lett. 1990, 268, 149-151.
24. Irukayama-Tomobe, Y., Miyauchi, T., Sakai, S., Kasuya, Y. et al., Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway. Circulation 2004, 109, 904-910.
25. Huang, Y., Zhang, H., Shao, Z., O'Hara, K. A. et al., Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta. Cardiovasc. Res. 2011, 90, 267-275.
26. Vine, D. F., Croft, K. D., Beilin, L. J., Mamo, J. C., Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons. Lipids 1997, 32, 887-893.
27. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
28. Cruz-Hernandez, C., Kramer, J. K., Kennelly, J. J., Glimm, D. R. et al., Evaluating the conjugated linoleic acid and trans 18:1 isomers in milk fat of dairy cows fed increasing amounts of sunflower oil and a constant level of fish oil. J. Dairy Sci. 2007, 90, 3786-3801.
29. Schmidt, M. V., Brune, B., von Knethen, A., The nuclear hormone receptor PPARgamma as a therapeutic target in major diseases. Sci. World J. 2010, 10, 2181-2197.
30. Bonen, A., Holloway, G. P., Tandon, N. N., Han, X. X. et al., Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297, R1202-R1212.
31. Holloway, G. P., Jain, S. S., Bezaire, V., Han, X. X. et al., FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297, R960-R967.
32. Chen, G., Liang, G., Ou, J., Goldstein, J. L. et al., Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. USA 2004, 101, 11245-11250.
33. Jacome-Sosa, M. M., Lu, J., Wang, Y., Ruth, M. R. et al., Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat. Nutr. Metab. (Lond.) 2010, 7, 60-70.
34. Pan, H. J., Lin, Y., Chen, Y. E., Vance, D. E. et al., Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. Vasc. Pharmacol. 2006, 45, 65-71.
35. Loke, Y. K., Kwok, C. S., Singh, S., Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ 2011, 342, d1309-1317.
36. Adlof, R. O., Duval, S., Emken, E. A., Biosynthesis of conjugated linoleic acid in humans. Lipids 2000, 35, 131-135.
37. Dietz, W. H., Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998, 101, 518-525.
38. Schreurs, M., Kuiper, F., van de Leij, F. R., Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes. Res. 2010, 11, 380-388.
39. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., Wahli, W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137, 354-366.
40. Pyper, S. R., Viswakarma, N., Yu, S., Reddy, J. K., PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl. Recept. Signal 2010, 8, e002.
41. Hassanali, Z., England, A., O'Neill, D., MacNaughton, K. et al., Intestinal villi hypertrophy is associated with overproduction of lymphatic chylomicrons during conditions of obesity and hyperinsulinemia in the JCR:LA-cp rodent. Atherosc. Suppl. 2008, 9, 90-91.
42. Mottram, H. R., Crossman, Z. M., Evershed, R. P., Regiospecific characterisation of the triacylglycerols in animal fats using high performance liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry. Analyst 2001, 126, 1018-1024.